Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of SeraCare Life Sciences
14 Febrero 2012 - 10:42AM
Business Wire
Holzer Holzer & Fistel, LLC is investigating whether the
directors of SeraCare Life Sciences, Inc. (“SeraCare” or the
“Company”) (NASDAQ: SRLS) complied with their fiduciary duties in
approving the proposed acquisition of the Company by Linden Capital
Partners. According to the Company’s announcement, if the deal
closes SeraCare shareholders will receive $4.00 per share of SRLS
owned. The investigation seeks to determine, among other things,
whether the consideration to be paid to SeraCare shareholders is
fair and adequate.
Current holders of SeraCare common stock with questions
concerning their legal rights are encouraged to contact Holzer
Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr.,
Esq., or Marshall P. Dees, Esq. via email at
mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via
toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC dedicates its practice to
vigorous representation of shareholders and investors in litigation
nationwide, including shareholder class action and derivative
litigation. More information about the firm is available through
its website, www.holzerlaw.com and upon request from the
firm. Holzer Holzer & Fistel, LLC has paid for the
dissemination of this promotional communication, and Michael I.
Fistel, Jr. is the attorney responsible for its content.
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Seracare Life Sciences (MM) (NASDAQ): 0 recent articles
Más de Holzer Holzer & Fistel, LLC Artículos de Noticias